No Data
No Data
The Journal of American Medical Association (JAMA) Publishes Elinzanetant Phase III Data
Bayer Initiates Phase II Study of Soluble Guanylate Cyclase Activator (BAY3283142) in Patients With Chronic Kidney Disease
Bristol Myers Bid to Expand Label for Liver Cancer Drug Under FDA Review
Market Chatter: Bayer Reportedly Plans to Axe 150 Jobs in Switzerland
Trending: Bayer Gets Favorable Appeals Court Ruling in Roundup Case
Propelled by optimistic sentiment towards economic growth, European stock markets have seen their biggest weekly gain since May.
European stock markets rose on Friday, reaching their biggest weekly gain since May. Global economic data has been generally positive, easing concerns about economic health. The Stoxx Europe 600 Index closed up 0.3%, but fell from its intraday high after disappointing US housing data. Autos and retail stocks had the largest gains, while energy and real estate stocks lagged behind. The Italy FTSE MIB Index jumped 2.2%, outperforming regional benchmark stock indices as Italian markets resumed trading after the holiday on Thursday. On the individual stock side, Bayer's stock price rose after the company achieved a major victory in a long-standing cancer lawsuit in the United States. New US construction in July.
No Data